It covers the provider's work in administering the injection, not the drug itself
Individuals using GLP-1 medications may experience: Reduced caloric and protein intake Early satiety or nausea Gastrointestinal changes that affect absorption Increased fatigue during metabolic adjustment Because B-complex vitamins support energy metabolism, neurological pathways, and gastrointestinal integrity, supportive supplementation may be considered when intake is reduced or oral tolerance is limited
If you find it useful, subscribe to my Substack for more in-depth content, exclusive case studies, and clinical insights
All of that evidence, taken together, has led Mapp and other researchers to question a key detail of BPC-157s origin story: Theyre not convinced its actually produced by the body at all
Each compound in this blend has been reviewed in scientific literature for its potential role in metabolic and cellular research